Partnering Opportunities

Plexxikon succeeds through innovative partnerships. For inquiries about the Plexxikon pipeline, contact bd@plexxikon.com 

We are currently seeking partners for the following products:

  • PLX7486 – a pan-NTRK inhibitor that has completed Phase 1 studies
  • PLX204 – a pan-PPAR agonist that has completed Phase 2a studies